Hepatocyte-specific deletion of Pparα promotes NAFLD in the context of obesity

Archive ouverte

Régnier, Marion | Polizzi, Arnaud | Smati, Sarra | Lukowicz, Céline | Fougerat, Anne | Lippi, Yannick | Fouché, Edwin | Lasserre, Frédéric | Naylies, Claire | Bétoulières, Colette | Barquissau, Valentin | Mouisel, Etienne | Bertrand-Michel, Justine | Batut, Aurélie | Saati, Talal Al | Canlet, Cécile | Tremblay-Franco, Marie | Ellero-Simatos, Sandrine | Langin, Dominique | Postic, Catherine | Wahli, Walter | Loiseau, Nicolas | Guillou, Hervé | Montagner, Alexandra

Edité par CCSD ; Nature Publishing Group -

International audience. Peroxisome proliferator activated receptor α (PPARα) acts as a fatty acid sensor to orchestrate the transcription of genes coding for rate-limiting enzymes required for lipid oxidation in hepatocytes. Mice only lacking Pparα in hepatocytes spontaneously develop steatosis without obesity in aging. Steatosis can develop into non alcoholic steatohepatitis (NASH), which may progress to irreversible damage, such as fibrosis and hepatocarcinoma. While NASH appears as a major public health concern worldwide, it remains an unmet medical need. In the current study, we investigated the role of hepatocyte PPARα in a preclinical model of steatosis. For this, we used High Fat Diet (HFD) feeding as a model of obesity in C57BL/6 J male Wild-Type mice (WT), in whole-body Pparα- deficient mice (Pparα-/-) and in mice lacking Pparα only in hepatocytes (Pparαhep-/-). We provide evidence that Pparα deletion in hepatocytes promotes NAFLD and liver inflammation in mice fed a HFD. This enhanced NAFLD susceptibility occurs without development of glucose intolerance. Moreover, our data reveal that non-hepatocytic PPARα activity predominantly contributes to the metabolic response to HFD. Taken together, our data support hepatocyte PPARα as being essential to the prevention of NAFLD and that extra-hepatocyte PPARα activity contributes to whole-body lipid homeostasis.

Suggestions

Du même auteur

Liver gene expression and its rewiring in hepatic steatosis are controlled by PI3Kα-dependent hepatocyte signaling

Archive ouverte | Régnier, Marion | CCSD

International audience. Insulin and other growth factors are key regulators of liver gene expression, including in metabolic diseases. Most of the phosphoinositide 3-kinase (PI3K) activity induced by insulin is cons...

Insights into the role of hepatocyte PPARα activity in response to fasting

Archive ouverte | Régnier, Marion | CCSD

The liver plays a central role in the regulation of fatty acid metabolism. Hepatocytes are highly sensitive to nutrients and hormones that drive extensive transcriptional responses. Nuclear hormone receptors are key transcription ...

Integrative study of diet-induced mouse models of NAFLD identifies PPARα as a sexually dimorphic drug target

Archive ouverte | Smati, Sarra | CCSD

International audience. Objective We evaluated the influence of sex on the pathophysiology of non-alcoholic fatty liver disease (NAFLD). We investigated diet-induced phenotypic responses to define sex-specific regul...

Chargement des enrichissements...